Urogen Pharma (URGN)
(Delayed Data from NSDQ)
$13.61 USD
+0.37 (2.79%)
Updated May 28, 2024 04:00 PM ET
After-Market: $13.59 -0.02 (-0.15%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.86 | -0.58% |
Earnings Summary
For their last quarter, Urogen Pharma (URGN) reported earnings of -$0.97 per share, missing the Zacks Consensus Estimate of -$0.93 per share. This reflects a negative earnings surprise of 4.30%. Look out for URGN's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.86 per share, reflecting a year-over-year increase of 16.5%.
Earnings History
Price & Consensus
Zacks News for URGN
Urogen Pharma (URGN) Reports Q4 Loss, Tops Revenue Estimates
URGN: What are Zacks experts saying now?
Zacks Private Portfolio Services